Market News

MediWound (NASDAQ:MDWD) Drops on $30M Securities Offerings

Shares of Biopharmaceutical company MediWound (NASDAQ:MDWD) are tanking today owing to a registered securities offering of ~7.57 million shares and ~9.85 million warrants which will enable accredited investors in the agreement to acquire additional shares of the company.

MDWD expects to raise gross proceeds of ~$30.5 million from the offerings.  It plans to use the funds to scale up its facilities and for the development of EscharEx.

Additionally, it could also use a part of the funds to in-license or invest into or acquire other assets.

Read full Disclosure

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More